Abstract
Background Antipsychotic polypharmacy (APP) occurs commonly but it is unclear whether it is associated with an increased risk of adverse drug reactions. Electronic health records (EHRs) offer an opportunity to examine APP using real-world data. In this study, we use EHR data to identify periods when patients were prescribed 2+ antipsychotics and compare these with periods of antipsychotic monotherapy. To determine the relationship between APP and subsequent instances of adverse drug reactions: QT interval prolongation, hyperprolactinaemia, and increased body weight (body mass index [BMI] ≥ 25).
Methods We extracted anonymised EHR data. Patients aged 16+ receiving antipsychotic medication at Camden & Islington NHS Foundation Trust between 1 January 2008 and 31 December 2018 were included. Multilevel mixed-effects logistic regression models were used to elucidate the relationship between APP and the subsequent presence of QT interval prolongation, hyperprolactinaemia, and/or increased BMI following a period of APP within 7, 30, or 180 days respectively.
Results We identified 35,409 observations of antipsychotic prescribing among 13,391 patients. APP was associated with a subsequent increased risk of hyperprolactinaemia (adjusted odds ratio 2.46; 95% C.I. 1.87-3.24) and of having a BMI > 25 (adjusted odds ratio 1.75; 95% C.I. 1.33-2.31) in the period following the APP prescribing.
Conclusions Our observations suggest that APP should be carefully managed with attention to hyperprolactinaemia and obesity.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Medical Research Council (MC_PC_17216)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Research approval for the C&I NHS FT CRIS research database was obtained from the East of England - Cambridge Central Research Ethics Committee (19/EE/0210), and the project protocol was reviewed and approved by the C&I NHS FT Research Oversight Committee.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* First authors
Declaration of Interest: Justin C. Yang, Johan H. Thygesen, Nomi Werbeloff, Joseph F. Hayes, and David P.J. Osborn have no interests to declare.
Funding Statement: This work was supported by the Medical Research Council (MC_PC_17216).
Data Availability: The data that support the findings of this study are available to approved researchers through Camden & Islington NHS Foundation Trust. The data are not publicly available due to restrictions on data access by the Data Controller in the interest of patient confidentiality.
Data Availability
Data used in this article can only be access by approved researchers, using the C&I CRIS research database. If you would like further information about using CRIS at C&I for a project, please contact the C&I Research Database Manager by emailing researchdatabase{at}candi.nhs.uk. If you would like to submit an application for permission to use CRIS for a research project, please download the project application form here.
https://www.candi.nhs.uk/health-professionals/research/ci-research-database
